Literature DB >> 30891797

Composite interaction tree for simultaneous learning of optimal individualized treatment rules and subgroups.

Xin Qiu1, Yuanjia Wang1,2.   

Abstract

Treatment response heterogeneity has long been observed in patients affected by chronic diseases. Administering an individualized treatment rule (ITR) offers an opportunity to tailor treatment strategies according to patient-specific characteristics. Overly complex machine learning methods for estimating ITRs may produce treatment rules that have higher benefit but lack transparency and interpretability. In clinical practices, it is desirable to derive a simple and interpretable ITR while maintaining certain optimality that leads to improved benefit in subgroups of patients, if not on the overall sample. In this work, we propose a tree-based robust learning method to estimate optimal piecewise linear ITRs and identify subgroups of patients with a large benefit. We achieve these goals by simultaneously identifying qualitative and quantitative interactions through a tree model, referred to as the composite interaction tree (CITree). We show that it has improved performance compared to existing methods on both overall sample and subgroups via extensive simulation studies. Lastly, we fit CITree to Research Evaluating the Value of Augmenting Medication with Psychotherapy trial for treating patients with major depressive disorders, where we identified both qualitative and quantitative interactions and subgroups of patients with a large benefit.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  mental disorders; personalized medicine; qualitative interaction; quantitative interaction; tree-based method

Mesh:

Year:  2019        PMID: 30891797     DOI: 10.1002/sim.8105

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  1 in total

1.  Synthesizing independent stagewise trials for optimal dynamic treatment regimes.

Authors:  Yuan Chen; Yuanjia Wang; Donglin Zeng
Journal:  Stat Med       Date:  2020-08-17       Impact factor: 2.373

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.